Literature DB >> 3494062

Normal human sera contain antibodies directed at Fab of IgA.

S Jackson, R I Montgomery, J Mestecky, C Czerkinsky.   

Abstract

Serum samples from 26 normal volunteers were evaluated by isotype-specific ELISA for the presence of IgG and IgM antibodies directed at IgA. Although there were wide variations in antibody levels, anti-IgA antibodies of both isotypes were found in all individuals tested. The anti-IgA activity was detected against a variety of polymeric and monomeric IgA1 and IgA2 myeloma proteins containing both kappa and lambda light chains. By using Fab and Fc fragments generated by incubation of an IgA1 myeloma protein with IgA1 protease, it was shown that the anti-IgA activity was specific for the Fab portion of the IgA molecule. It was also demonstrated that the serum of two individuals contained both IgG and IgM activity directed at autologous affinity-purified IgA. IgM antibody levels against both whole IgA and Fab of IgA were significantly higher than IgG antibody levels. Cells producing anti-IgA antibodies of both isotypes were detected in lipopolysaccharide-stimulated human spleen.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3494062

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  Immunoglobulin and anti-Escherichia coli antibody in lower respiratory tract secretions from infants weighing less than 1500 g at birth.

Authors:  F H Sennhauser; A Balloch; M J Shelton; L W Doyle; V Y Yu; D M Roberton
Journal:  Arch Dis Child       Date:  1990-01       Impact factor: 3.791

2.  Long-term follow-up of anti-IgA antibodies in healthy IgA-deficient adults.

Authors:  S Koskinen; H Tölö; M Hirvonen; J Koistinen
Journal:  J Clin Immunol       Date:  1995-07       Impact factor: 8.317

3.  Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies.

Authors:  M Tomana; J Novak; B A Julian; K Matousovic; K Konecny; J Mestecky
Journal:  J Clin Invest       Date:  1999-07       Impact factor: 14.808

4.  Antibodies to polyclonal IgA, IgA1, and IgA2 and isotype-specific immune complexes in IgA nephropathy.

Authors:  C L Jones; C S Hosking; P Kincaid-Smith; H R Powell; S C Richardson; F H Sennhauser; D M Roberton
Journal:  J Clin Immunol       Date:  1989-07       Impact factor: 8.317

5.  IgG anti-IgA subclasses in common variable immunodeficiency and association with severe adverse reactions to intravenous immunoglobulin therapy.

Authors:  R de Albuquerque Campos; M N Sato; A J da Silva Duarte
Journal:  J Clin Immunol       Date:  2000-01       Impact factor: 8.317

6.  Anti-IgA antibodies in IgA-deficient children.

Authors:  F H Sennhauser; C S Hosking; C L Jones; R A MacDonald; N Mermelstein; D M Roberton
Journal:  J Clin Immunol       Date:  1988-09       Impact factor: 8.317

Review 7.  IgA nephropathy enigma.

Authors:  Jiri Mestecky; Jan Novak; Zina Moldoveanu; Milan Raska
Journal:  Clin Immunol       Date:  2016-07-18       Impact factor: 3.969

Review 8.  Role of aberrant glycosylation of IgA1 molecules in the pathogenesis of IgA nephropathy.

Authors:  J Mestecky; M Tomana; Z Moldoveanu; B A Julian; H Suzuki; K Matousovic; M B Renfrow; L Novak; R J Wyatt; J Novak
Journal:  Kidney Blood Press Res       Date:  2008-01-08       Impact factor: 2.687

9.  Protamine-reactive natural IgM antibodies in human sera. Characterization of the epitope demonstrates specificity of antigenic recognition; occurrence indicates obscurity of origin and function.

Authors:  T C Rodman; F H Pruslin; Y Chauhan; S E To; R Winston
Journal:  J Exp Med       Date:  1988-03-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.